TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
INO

Inovio Pharmaceuticals Inc

Healthcare · Biotechnology

1.90$ +213.7% vs. previous close Closing price · As of: Nov 2, 2026

Statements

Income Statement

Inovio Pharmaceuticals Inc (INO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.1 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement INO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
10 41 35 42 30 4.1 7.4 1.8 10 0.8 0.2 0.1
48 58 89 99 95 88 94 4.7 5.5 3.5 3.1 3.0
10 41 35 42 30 4.1 7.4 1.8 10 0.8 -2.9 0.1
34 58 89 99 95 88 94 249 188 87 76 54
16 18 24 28 29 27 37 54 90 48 36,996 33
50 76 113 127 125 115 131 303 278 145 111 87
-39 -34 -76 -84 -94 -111 -124 -301 -268 -144 -112 -87
3.4 5.2 0.1 0.0 0.3 7.9 8.7 1.9 1.3 1.2 0.2 0.0
-36 -31 -74 -88 -95 -121 -167 -304 -280 -135 -107 -85
-3.7 -2.1 -4.6 1.8 2.2 -0.3 52 0.4 2.2 0.0 -107,147 –
-36 -29 -74 -88 -97 -119 -166 -304 -280 -135 -107 -85
-38 -33 -74 -85 -90 -107 -150 -297 -271 -130 -104 -82

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?